$1.65 Billion is the total value of Alphabet Inc.'s 27 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 16.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
LYFT | Lyft Inc | $551,902,000 | +5.3% | 12,828,964 | 0.0% | 33.38% | +112.0% | |
JD | JD com Incspon adr cl a | $477,489,000 | +24.9% | 13,553,474 | 0.0% | 28.88% | +151.4% | |
DXCM | Buy | Dexcom Inc | $176,235,000 | +969.1% | 805,681 | +629.4% | 10.66% | +2052.9% |
UBER | Sell | Uber Technologies Inc | $112,454,000 | -94.8% | 3,781,241 | -94.7% | 6.80% | -89.6% |
RCUS | Arcus Biosciences Inc | $51,003,000 | +11.0% | 5,049,786 | 0.0% | 3.08% | +123.3% | |
MGTA | Magenta Therapeutics Inc | $50,621,000 | +47.8% | 3,339,138 | 0.0% | 3.06% | +197.5% | |
FTSV | Sell | Forty Seven Inc | $40,576,000 | +308.8% | 1,030,644 | -33.3% | 2.45% | +723.5% |
WORK | Slack Technologies Inc. | $29,219,000 | -5.3% | 1,299,771 | 0.0% | 1.77% | +90.6% | |
NET | Cloudflare Inc | $27,851,000 | -8.1% | 1,632,519 | 0.0% | 1.68% | +84.9% | |
RAPT | New | RAPT Therapeutics Inc | $23,084,000 | – | 836,059 | +100.0% | 1.40% | – |
VIR | New | Vir Biotechnology Inc | $20,958,000 | – | 1,666,666 | +100.0% | 1.27% | – |
FULC | Fulcrum Therapeutics Inc | $11,886,000 | +150.6% | 714,285 | 0.0% | 0.72% | +406.3% | |
SPRO | Spero Therapeutics Inc | $10,696,000 | -9.3% | 1,112,473 | 0.0% | 0.65% | +82.8% | |
CRTX | Sell | Cortexyme Inc | $10,617,000 | +36.4% | 189,122 | -39.4% | 0.64% | +174.4% |
AUTL | Autolus Therapeutics PLCspon ads | $9,231,000 | +6.3% | 699,352 | 0.0% | 0.56% | +113.8% | |
SNAP | Snap Inccl a | $8,552,000 | +3.3% | 523,710 | 0.0% | 0.52% | +107.6% | |
CRWD | Buy | Crowdstrike Hldgs Inccl a | $8,529,000 | +4.5% | 171,020 | +22.2% | 0.52% | +110.6% |
GRTS | Gritstone Oncology Inc | $8,333,000 | +3.9% | 929,022 | 0.0% | 0.50% | +109.1% | |
MWK | Mohawk Group Hldgs Inc | $6,220,000 | -24.7% | 1,055,954 | 0.0% | 0.38% | +51.6% | |
IDYA | Ideaya Biosciences Inc | $5,649,000 | -16.7% | 753,187 | 0.0% | 0.34% | +67.6% | |
CLDR | Cloudera Inc | $4,974,000 | +31.2% | 427,710 | 0.0% | 0.30% | +164.0% | |
EVLO | Evelo Biosciences Inc | $4,306,000 | -33.4% | 1,060,495 | 0.0% | 0.26% | +34.0% | |
ALEC | Sell | Alector Inc | $3,030,000 | +6.4% | 175,866 | -10.9% | 0.18% | +112.8% |
DBX | Dropbox Inccl a | $233,000 | -11.4% | 13,033 | 0.0% | 0.01% | +75.0% | |
SPGI | Exit | S&P Global Inc | $0 | – | -1,297 | -100.0% | -0.01% | – |
SQ | Exit | Square Inccl a | $0 | – | -12,342 | -100.0% | -0.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPERO THERAPEUTICS INC | 24 | Q3 2023 | 3.5% |
AUTOLUS THERAPEUTICS PLC | 22 | Q3 2023 | 2.8% |
Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
DEXCOM INC | 20 | Q3 2023 | 17.4% |
Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
ALECTOR INC | 19 | Q3 2023 | 1.1% |
Lyft Inc | 18 | Q2 2023 | 51.9% |
QUINCE THERAPEUTICS INC | 18 | Q3 2023 | 0.6% |
Arcus Biosciences Inc | 17 | Q1 2022 | 12.7% |
FULCRUM THERAPEUTICS INC | 17 | Q3 2023 | 0.7% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
10-Q | 2024-04-26 |
144 | 2024-04-26 |
4 | 2024-04-26 |
4 | 2024-04-26 |
ARS | 2024-04-26 |
DEF 14A | 2024-04-26 |
DEFA14A | 2024-04-26 |
8-K | 2024-04-25 |
144 | 2024-04-17 |
144 | 2024-04-17 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.